| Date | Time | Source | Headline | Symbol | Company |
| 11/11/2022 | 2:00AM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 11/10/2022 | 4:20PM | Alliance News |  IN BRIEF: MaxCyte records good revenue growth in third quarter | LSE:MXCT | Maxcyte Inc |
| 11/10/2022 | 2:01AM | UK Regulatory | MaxCyte, Inc. Filing of Form 10-Q | LSE:MXCT | Maxcyte Inc |
| 11/10/2022 | 2:00AM | UK Regulatory | MaxCyte, Inc. MaxCyte Reports Third Quarter Financial Results | LSE:MXCT | Maxcyte Inc |
| 11/09/2022 | 5:35PM | PR Newswire (US) | MaxCyte Reports Third Quarter 2022 Financial Results | LSE:MXCT | Maxcyte Inc |
| 11/02/2022 | 8:05AM | RNS Non-Regulatory | MaxCyte, Inc. Participation in Upcoming Investor Conferences | LSE:MXCT | Maxcyte Inc |
| 11/01/2022 | 5:25AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 10/17/2022 | 9:58AM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 10/12/2022 | 8:00AM | UK Regulatory | MaxCyte, Inc. Notice of Third Quarter 2022 Financial Results | LSE:MXCT | Maxcyte Inc |
| 10/03/2022 | 4:42AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights and Block Listing Return | LSE:MXCT | Maxcyte Inc |
| 09/28/2022 | 4:38PM | Alliance News | TRADING UPDATES: LoopUp, Surface raise capital; MaxCyte wins deal | LSE:MXCT | Maxcyte Inc |
| 09/28/2022 | 8:05AM | UK Regulatory | MaxCyte, Inc. Signing of Strategic Platform License | LSE:MXCT | Maxcyte Inc |
| 09/21/2022 | 8:05AM | RNS Non-Regulatory | MaxCyte, Inc. New Maryland headquarters | LSE:MXCT | Maxcyte Inc |
| 09/08/2022 | 2:01AM | RNS Non-Regulatory | MaxCyte, Inc. Morgan Stanley Healthcare Conference Participation | LSE:MXCT | Maxcyte Inc |
| 09/01/2022 | 11:39AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 08/11/2022 | 2:00AM | UK Regulatory | MaxCyte, Inc. Second Quarter and Half-Year Results | LSE:MXCT | Maxcyte Inc |
| 08/11/2022 | 2:00AM | UK Regulatory | MaxCyte, Inc. Filing of Form 10-Q for Second Quarter | LSE:MXCT | Maxcyte Inc |
| 08/10/2022 | 5:01PM | Alliance News | IN BRIEF: MaxCyte grows revenue but widens loss in second quarter | LSE:MXCT | Maxcyte Inc |
| 08/10/2022 | 4:05PM | PR Newswire (US) | MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results | LSE:MXCT | Maxcyte Inc |
| 08/02/2022 | 9:44AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 07/20/2022 | 5:00AM | UK Regulatory | MaxCyte, Inc. Change of Registered Office | LSE:MXCT | Maxcyte Inc |
| 07/15/2022 | 8:01AM | UK Regulatory | MaxCyte, Inc. Notice of Results | LSE:MXCT | Maxcyte Inc |
| 07/12/2022 | 9:05AM | Alliance News | IN BRIEF: MaxCyte enters strategic platform license agreement with LG | LSE:MXCT | Maxcyte Inc |
| 07/12/2022 | 8:01AM | UK Regulatory | MaxCyte, Inc. Signing of Strategic Platform License | LSE:MXCT | Maxcyte Inc |
| 07/12/2022 | 2:00AM | UK Regulatory | MaxCyte, Inc. Grant of Options | LSE:MXCT | Maxcyte Inc |
| 07/08/2022 | 12:16PM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 07/01/2022 | 2:00AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 06/30/2022 | 2:00AM | UK Regulatory | MaxCyte, Inc. Result of AGM | LSE:MXCT | Maxcyte Inc |
| 06/17/2022 | 9:51AM | UK Regulatory | MaxCyte, Inc. Holdings in Company | LSE:MXCT | Maxcyte Inc |
| 06/06/2022 | 2:02AM | UK Regulatory | MaxCyte, Inc. Publication of Annual Report | LSE:MXCT | Maxcyte Inc |